Association between sugammadex and anaphylaxis in pediatric patients: A nested case‐control study using a national inpatient database

Sugammadex is used as a reversal drug during anesthesia. Although several case reports have described anaphylaxis following sugammadex infusion, little is known about the relationship between sugammadex and anaphylaxis, particularly in pediatric patients.

[1]  H. Horiguchi,et al.  Validity of diagnoses, procedures, and laboratory data in Japanese administrative data , 2017, Journal of epidemiology.

[2]  Dong Kyu Lee,et al.  Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients , 2016, Medicine.

[3]  R. Tamagawa‐Mineoka,et al.  Anaphylaxis caused by γ-cyclodextrin in sugammadex. , 2016, Allergology international : official journal of the Japanese Society of Allergology.

[4]  T. Takazawa,et al.  Sugammadex and rocuronium-induced anaphylaxis , 2015, Journal of Anesthesia.

[5]  D. Hepner,et al.  Perioperative Anaphylaxis: What Should Be Known? , 2015, Current Allergy and Asthma Reports.

[6]  J. V. van Schalkwyk,et al.  Anaphylaxis Is More Common with Rocuronium and Succinylcholine than with Atracurium , 2015, Anesthesiology.

[7]  C. Camargo,et al.  Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. , 2014, The Journal of allergy and clinical immunology.

[8]  A. Kalansky,et al.  Hypersensitivity associated with sugammadex administration: a systematic review , 2014, Anaesthesia.

[9]  Chie Nagata,et al.  Three suspected cases of sugammadex-induced anaphylactic shock , 2014, BMC Anesthesiology.

[10]  H. Mosbech,et al.  Transfusion‐associated anaphylaxis during anaesthesia and surgery – a retrospective study , 2014, Vox sanguinis.

[11]  P. Platt,et al.  Intraoperative Anaphylaxis to Sugammadex and a Protocol for Intradermal Skin Testing , 2014, Anaesthesia and intensive care.

[12]  N. Nanjappa,et al.  Sugammadex Hypersensitivity—A Case of Anaphylaxis , 2014, Anaesthesia and intensive care.

[13]  J. Kotani,et al.  Hypersensitivity reaction probably induced by sugammadex. , 2012, Acta anaesthesiologica Taiwanica : official journal of the Taiwan Society of Anesthesiologists.

[14]  A. Matsunaga,et al.  Three cases of suspected sugammadex-induced hypersensitivity reactions. , 2012, British journal of anaesthesia.

[15]  N. Pham,et al.  Drug‐specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  L. Green,et al.  Sugammadex in the management of rocuronium-induced anaphylaxis. , 2011, British journal of anaesthesia.

[17]  A. Sheikh,et al.  World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis , 2011, The World Allergy Organization journal.

[18]  D. Chambers,et al.  Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. , 2010, British journal of anaesthesia.

[19]  A. Gonzáléz-Pérez,et al.  Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. , 2010, The Journal of allergy and clinical immunology.

[20]  P. Mouriquand,et al.  Latex allergy in children: modalities and prevention , 2009, Paediatric anaesthesia.

[21]  B. Plaud,et al.  Reversal of Rocuronium-induced Neuromuscular Blockade with Sugammadex in Pediatric and Adult Surgical Patients , 2009, Anesthesiology.

[22]  P. Newberne,et al.  Safety assessment of ?-cyclodextrin , 2004 .

[23]  H. Horiguchi,et al.  Clinical Epidemiology and Health Services Research using the Diagnosis Procedure Combination Database in Japan , 2015 .